Maxwell Sehested
Geen lopende functies
Loopbaan van Maxwell Sehested
Eerdere bekende functies van Maxwell Sehested
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 | - |
| TOPOTARGET A/S | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 | - |
| Oprichter | 27-05-2010 | - |
Statistieken
Internationaal
| Denemarken | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 2 |
| Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
- Beurs
- Insiders
- Maxwell Sehested
- Ervaring
